Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RIV Capital Inc CNPOF


Primary Symbol: C.RIV

RIV Capital Inc. is a Canada-based acquisition and investment company. The Company is focused on the United States (U.S.) cannabis market by acquiring, investing in, and developing operators and brands to create a multistate platform. The Company is a direct parent company of RIV Capital US Corporation and RIV Capital Corporation and exercises financial control over Etain, LLC. Through its strategic relationship with The Hawthorne Collective, Inc. (The Hawthorne Collective), a subsidiary of The ScottsMiracle-Gro Company (ScottsMiracle-Gro), the Company is The Hawthorne Collective's preferred vehicle for cannabis-related investments not under the purview of other ScottsMiracle-Gro subsidiaries. The Company's subsidiaries include 2683922 Ontario Inc., RIV Capital US Corporation, RIV Capital US Holdings LLC, RIV Capital US Real Estate LLC and RIV Capital US Services LLC.


CSE:RIV - Post by User

Post by AbrahamSTon May 10, 2019 3:49pm
154 Views
Post# 29735896

RIV is very Confident

RIV is very Confident Greetings,

Keeping you up to date with Canopy Rivers (TSX.V: RIV). The company is pleased to announce that its portfolio company, PharmHouse, has enter into a second offtake agreement with Canopy Growth. The agreement includes, Canopy Growth committing to buy an additional 20% of PharmHouse’s flowering space from their 1.3 million square foot facility for the next three years, which is in addition to the 10% that was agreed to in May 2018. PharmHouse will deliver between 25,000 kg and 45,000 kg of cannabis per year to Canopy Growth, over the next three years.
 
PharmHouse Article: Click Here
 
Would you like to discuss further?
 

All the best,

James Fairbanks
Investor Relations
Canopy Rivers Inc.
P: (647) 490-2063
E: james.fairbanks@canopyrivers.com
W: canopyrivers.com



1.


https://mailchi.mp/canopyrivers/canopy-rivers-tsxvriv-media-roundup-332599?e=a16d08f346




<< Previous
Bullboard Posts
Next >>